Since PSMD3 and not PSMD1 was upregulated in CML CD34+ cells (Fig. 3C), we assessed whether PSMD3 knockdown altered K562 proliferation in vivo. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.